Grosshansdorf is the first Mobilise-D site to reach their target number of participants in the Clinical Validation Study

We are very proud to announce that the Pulmonary Research Institute (PRI) in Grosshandorf, Schleswig-Holstein, Germany, is the first clinical site in our ongoing Clinical Validation Study that has reached their target number of included participants. They just reported that participant #140 has entered the Mobilise-D study, thereby completing their target for the COPD (Chronic…

Mobilise-D links with Voice Global to promote global patient engagement

We are pleased to announce that Mobilise-D is now using the Voice Global platform as part of our Patient and Public Involvement and Engagement (PPIE) activities.  Voice Global is an international network of citizens who come together to provide insights, ideas and experiences to researchers to help drive innovation for ageing and improve health research. Voice is a community of patients,…

Mobilise-D and IDEA-FAST announce the creation of the Digital Health Catalyst (DHC)

Mobilise-D and IDEA-FAST are pleased to announce the creation of the Digital Health Catalyst (DHC). Mobilise-D is working on digital mobility assessment in chronic obstructive pulmonary disease (COPD), Parkinson’s disease (PD), multiple sclerosis (MS) and recovery from proximal femoral fracture (PFF). IDEA-FAST is working to identify digital endpoints to assess fatigue, sleep disturbances and activities…